117 related articles for article (PubMed ID: 22049795)
1. [Expressions of integrinalpha2beta1 and CD133 in benign prostatic hyperplasia complicated by prostatitis and their significance].
Ding Q; Miao WL; Liu S; Chang JW; Yang YM
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):909-12. PubMed ID: 22049795
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
3. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.
Robert G; Descazeaud A; Nicolaïew N; Terry S; Sirab N; Vacherot F; Maillé P; Allory Y; de la Taille A
Prostate; 2009 Dec; 69(16):1774-80. PubMed ID: 19670242
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
7. Prostatitis in benign prostatic hyperplasia: a histological, bacteriological and clinical study.
Bedalov G; Vucković I; Fridrih S; Bruk M; Puskar D; Bartolin Z
Acta Med Croatica; 1994; 48(3):105-9. PubMed ID: 7532045
[TBL] [Abstract][Full Text] [Related]
8. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
11. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
14. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
15. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of platelet-derived growth factor with benign prostatic hyperplasia].
Chu J; Zhong HX
Zhonghua Nan Ke Xue; 2007 Oct; 13(10):932-5. PubMed ID: 17977330
[TBL] [Abstract][Full Text] [Related]
17. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome.
Zang L; Tian F; Yao Y; Chen Y; Shen Y; Han M; Meng Z; Fan S; Zhang X; Cai T; Gao Q; Zhang Y; Lu J
J Cell Mol Med; 2021 Jun; 25(12):5753-5768. PubMed ID: 33982874
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between anaphylatoxin C3a and benign prostatic hyperplasia with inflammation].
Xie L; Cheng SL; Li YZ; Liu LR; Han P; Chen N; Wei Q; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):642-5. PubMed ID: 22007489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
